Andre O. Cacais-Guerreiro
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
High-throughput primary B cell cytokines assay for drug screening in multiple sclerosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 11, 2026
Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis.
Journal: Cell
Published: January 29, 2025
Disease-associated oligodendroglia: a putative nexus in neurodegeneration.
Journal: Trends in immunology
Published: July 19, 2024
Distinct transcriptomic and epigenomic responses of mature oligodendrocytes during disease progression in a mouse model of multiple sclerosis.
Journal: Nature neuroscience
Published: December 10, 2023
Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology.
Journal: Cell
Published: June 18, 2023
Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis.
Journal: Science advances
Published: May 17, 2023
The aging mouse CNS is protected by an autophagy-dependent microglia population promoted by IL-34.
Journal: Nature communications
Published: February 08, 2023
A pan-cancer signature for dysfunctional T cells.
Journal: Nature reviews. Immunology
Published: December 16, 2021
Myeloid cell-specific topoisomerase 1 inhibition using DNA origami mitigates neuroinflammation.
Journal: EMBO reports
Published: December 12, 2021
Microglial autophagy-associated phagocytosis is essential for recovery from neuroinflammation.
Journal: Science immunology
Published: February 28, 2020
IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 26, 2020
Last Updated: 09/26/2026